Search clinical trials for: Saccharomyces Boulardii 250 MG

Total 1828 results

Fakultas Kedokteran Universitas Indonesia

Not yet recruiting

The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

Irritable Bowel Syndrome
Tatyasaheb Kore Dental College

Completed

Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis

Chronic Periodontitis

India
Clinical Centre of Serbia
Institute for Pulmonary Diseases of Vojvodina

Completed

S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections

Anti-Bacterial Agents | Prevention & Control | Diarrhea Caused by Drug | Respiratory Infection Bacterial

Serbia
Centro de Educación Medica e Investigaciones Clínicas...

Completed

Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth

Irritable Bowel Syndrome

Argentina
Biocodex

Completed

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

HIV Infections | Diarrhea

United States
Universidade Federal Fluminense

Completed

A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA (PROICA)

Heart Failure

Brazil
Coordinación de Investigación en Salud, Mexico

Completed

Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis

Systemic Sclerosis | Small Intestinal Bacterial Overgrowth

Mexico
Federal University of Minas Gerais

Completed

Impact of Probiotics on the Intestinal Microbiota

Colorectal Cancer
Biocodex

Completed

Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children (SABINA)

Acute Gastroenteritis

Argentina
Zekai Tahir Burak Women's Health Research and Education...

Unknown

Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants

Necrotizing Enterocolitis | Very Low Birth Weight Infants

Turkey
Aga Khan University

Unknown

Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome (SBIBS)

Irritable Bowel Syndrome

Pakistan
Federal University of Minas Gerais

Completed

Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant

Liver Cirrhosis

Brazil
Sinaloa Pediatric Hospital

Withdrawn

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

Gastroenteritis

Mexico
Azienda di Servizi alla Persona di Pavia

Completed

Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation in Obese Adults

Obesity | Superoxide Dismutase

Italy
Maria Isabel Toulson Davisson Correia

Completed

Impact of Probiotics in Modulation of Intestinal Microbiota

Colorectal Cancer

Brazil
Ann & Robert H Lurie Children's Hospital of Chicago

Recruiting

A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections

Recurrent Uti

United States
Instituto Mexicano del Seguro Social

Completed

Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.

Viral Diarrhea

Mexico
Aga Khan University
Biocodex

Completed

Saccharomyces Boulardii in Irritable Bowel Syndrome (SB-IBS)

Diarrhea Dominant Irritable Bowel Syndrome

Pakistan
Cultech Ltd
Comac Medical

Completed

The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function and/or Faecal Microbiota Composition (FANTIB)

Antibiotic Side Effect

Bulgaria
I.M. Sechenov First Moscow State Medical University

Completed

Probiotics and Hemodynamic Changes in Cirrhosis (PrBHCCir)

Cirrhosis

Russian Federation
Universidad San Francisco de Quito
Biocodex; Universidad Tecnológica Equinoccial

Completed

Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy

Gut Resistome
McNeil AB

Completed

A Comparison of Three Medications to Treat Diarrhea in Adults.

Diarrhea

India, Mexico
Oslo University Hospital

Unknown

GutHeart: Targeting Gut Microbiota to Treat Heart Failure

Systolic Heart Failure

Norway
Evangelos J. Giamarellos-Bourboulis, M.D.
Aristotle University Of Thessaloniki

Completed

Probiotics in the Prevention of Complications After Colorectal Surgery

Postoperative Complications
Beth Israel Deaconess Medical Center
Hong Kong Association for Health Care; Integrated Chinese Medicine Holdings

Completed

Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota

Human Gut Microbiota

United States
Medical University of Lodz

Completed

Probiotics and Examination-related Stress in Healthy Medical Students

Healthy | Anxiety | Stress-related Problem
Bernhard Nocht Institute for Tropical Medicine
German Federal Ministry of Education and Research

Terminated

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (SacBo)

Diarrhea | Antibiotic-associated Diarrhea | Clostridium Difficile

Germany
Impax Laboratories, LLC

Completed

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Takeda

Completed

Single-Dose Phase 1 Study of TAK-792

Healthy Male Adults Participants

Japan
Cephalon

Completed

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Chronic Shift Work Sleep Disorder

United States
NeuroBo Pharmaceuticals Inc.

Completed

Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers

Hypercholesterolemia
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Regeneron Pharmaceuticals

Completed

Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Homozygous Familial Hypercholesterolemia

United States, Netherlands, Canada
Yuhan Corporation

Active, not recruiting

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Non-Small Cell Lung Cancer

Hungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
Hamamatsu University

Completed

Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication

Gastritis Associated With Helicobacter Pylori

Japan
The Center for Applied Health Sciences, LLC
Biohm Health, LLC

Completed

A Probiotic Blend Reduces Gastrointestinal Symptoms and Positively Impacts Microbiota Modulation in a Randomized Study

Constipation | Microbiota | Candida

United States
Janssen Pharmaceutical K.K.

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants

Respiratory Syncytial Virus Infections

Japan
Clinical Centre of Serbia

Unknown

Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii

Helicobacter Pylori Infection
aTyr Pharma, Inc.

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease

United States
AstraZeneca
Parexel

Active, not recruiting

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAURA)

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

Belgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
Novartis Pharmaceuticals

Recruiting

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Non-Small Cell Lung Carcinoma

India
MedImmune LLC
Amgen

Completed

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Asthma

United States, Slovakia, Israel, South Africa, Ukraine, Japan, Czechia, Hungary, Bulgaria, Serbia, Latvia, Lithuania
Lexicon Pharmaceuticals

Completed

An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects

Irritable Bowel Syndrome

United States
Mothaffar Rimawi

Terminated

CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer (CRIZENT)

Breast Cancer

United States
Innovation Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
Cytokinetics
Astellas Pharma Global Development, Inc.

Completed

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

Spinal Muscular Atrophy

United States, Canada
The Third Xiangya Hospital of Central South University

Completed

Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori

Helicobacter Pylori Infection

China
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Solid Tumor | Advanced Solid Tumor

Spain, United States, Netherlands, United Kingdom
Beth Israel Deaconess Medical Center
Biocodex

Completed

Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota

Healthy Volunteers

United States
Pfizer

Terminated

A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.

Healthy

Singapore

Search clinical trials for: Saccharomyces Boulardii 250 MG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations